BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21751586)

  • 1. Liver, a window to the heart in type 2 diabetes.
    Shukla A; Abraham P
    J Assoc Physicians India; 2011 Jun; 59():349. PubMed ID: 21751586
    [No Abstract]   [Full Text] [Related]  

  • 2. [Associated risk factors of fatty liver in the patients with type 2 diabetes mellitus].
    Chen QK; Chen HY; Wang LY; Zeng ZY; Zhou XD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):414-6. PubMed ID: 15268806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty liver is independently associated with alterations in circulating HDL2 and HDL3 subfractions.
    Kantartzis K; Rittig K; Cegan A; Machann J; Schick F; Balletshofer B; Fritsche A; Schleicher E; Häring HU; Stefan N
    Diabetes Care; 2008 Feb; 31(2):366-8. PubMed ID: 18000185
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss.
    Luyckx FH; Lefebvre PJ; Scheen AJ
    Diabetes Metab; 2000 Apr; 26(2):98-106. PubMed ID: 10804323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].
    Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal glucose tolerance and non-esterified fatty acids (NEFAs) as predictors of non-alcoholic steatohepatitis (NASH): which Ash that ignites the NASH.
    Osman MM; Osman KA; Ahmed MH
    J Clin Gastroenterol; 2007 Jan; 41(1):118-9. PubMed ID: 17198075
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
    Yki-Järvinen H
    Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does non-alcoholic fatty liver disease predispose patients to type 2 diabetes in the absence of obesity?
    Fan JG; Farrell GC
    J Gastroenterol Hepatol; 2010 Feb; 25(2):223-5. PubMed ID: 20136984
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Wu H; Jia W; Bao Y; Lu J; Zhu J; Wang R; Chen Y; Xiang K
    Diabetes Res Clin Pract; 2008 Feb; 79(2):185-90. PubMed ID: 17904683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic disorders related to obesity and periodontal disease.
    Saito T; Shimazaki Y
    Periodontol 2000; 2007; 43():254-66. PubMed ID: 17214843
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
    Kim CH; Park JY; Lee KU; Kim JH; Kim HK
    Diabetes Metab Res Rev; 2009 Jan; 25(1):64-9. PubMed ID: 19065605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
    McCullough AJ
    Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease: defining a common problem.
    Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients.
    Jin HB; Gu ZY; Yu CH; Li YM
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):389-92. PubMed ID: 16109522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: steatosis, the metabolic syndrome and cancer.
    Bugianesi E
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():40-3. PubMed ID: 16225471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of elevated alanine aminotransferase with BMI and diabetes in older veteran outpatients.
    Hermos JA; Cohen SA; Hall R; Gagnon DR; Brophy MT; Fiore LD
    Diabetes Res Clin Pract; 2008 Apr; 80(1):153-8. PubMed ID: 18178283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NASH and cardiovascular biomarkers.
    Ercin CN; Dogru T; Tasci I; Erdem G; Sonmez A; Tapan S
    Obesity (Silver Spring); 2009 Apr; 17(4):627; author reply 627. PubMed ID: 19322144
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes.
    Narasimhan S; Gokulakrishnan K; Sampathkumar R; Farooq S; Ravikumar R; Mohan V; Balasubramanyam M
    Clin Biochem; 2010 Jul; 43(10-11):815-21. PubMed ID: 20398645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic steatohepatitis is frequently accompanied by metabolic diseases.
    Dogru T; Ercin CN; Erdem G; Tasci I; Sonmez A; Tapan S
    Hepatology; 2008 Nov; 48(5):1728; author reply 1729. PubMed ID: 18972558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.